结论血浆置换治疗慢性乙型重型肝炎有肯定的治疗效果。
Conclusions Plasma exchange is effective in treating chronic B hepatitis.
结论拉米夫定治疗慢性乙型重型肝炎，可缓解病情，改善肝功能，抑制HBV复制，但对病死率无显著影响。
ConclusionPreliminary data indicate that lamivudine therapy can significantly improve liver function and effectively inhibit HBV replication, but not to effect the fatality rates.
目的探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效及其不良反应。
To observe the clinical effect and adverse effect of foscarnet sodium in treating patients with chronic severe hepatitis B.
结论恩替卡韦治疗慢性重型乙型肝炎具有较好的疗效和安全性。
Conclusion it can be concluded that Entecavir has good therapeutic efficiency and safety in the treatment of chronic severe hepatitis b.
方法：将61例慢性乙型重型肝炎患者随机分为治疗组和对照组。
Methods: 61 cases of chronic severe hepatitis patients were randomly divided into two groups.
ETV治疗慢性重型乙型肝炎有较好的安全性。
ETV has good security in the treatment for chronic severe hepatitis B.
ETV治疗慢性重型乙型肝炎有较好的安全性。
ETV has good security in the treatment for chronic severe hepatitis B.
应用推荐